BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rahman FZ, Takhar GK, Roy O, Shepherd A, Bloom SL, McCartney SA. Henoch-Schönlein purpura complicating adalimumab therapy for Crohn’s disease. World J Gastrointest Pharmacol Ther 2010; 1(5): 119-122 [PMID: 21577306 DOI: 10.4292/wjgpt.v1.i5.119]
URL: https://www.wjgnet.com/2150-5349/full/v1/i5/119.htm
Number Citing Articles
1
Carmen Muñoz Villafranca, Rosa Maria Izu Belloso, Maria Teresa Bravo Rodriguez, Susana Basterra Olabarrieta. Vasculitis por adalimumab en un paciente con enfermedad de CrohnGastroenterología y Hepatología 2013; 36(4): 296 doi: 10.1016/j.gastrohep.2012.10.004
2
Xiaolu Li, Yizhong Wang, Ting Ge, Yongmei Xiao, Ting Zhang. Henoch-Schönlein purpura associated with infliximab therapy for pediatric Crohn’s diseaseEuropean Journal of Gastroenterology & Hepatology 2021; 33(1S): e1074 doi: 10.1097/MEG.0000000000002046
3
Tumay Ak, Rana Berru Durmus, Muhammed Onel. Cutaneous vasculitis associated with molecular tergeted therapies: systematic review of the literatureClinical Rheumatology 2023; 42(2): 339 doi: 10.1007/s10067-022-06406-6
4
Joseph J. LaConti, Jean A. Donet, Jeong Hee Cho-Vega, Daniel A. Sussman, Dana Ascherman, Amar R. Deshpande. Henoch-Schönlein Purpura with Adalimumab Therapy for Ulcerative Colitis: A Case Report and Review of the LiteratureCase Reports in Rheumatology 2016; 2016: 1 doi: 10.1155/2016/2812980
5
M Villatoro-Villar, CS Crowson, KJ Warrington, A Makol, MJ Koster. Immunoglobulin A vasculitis associated with inflammatory bowel disease: a retrospective cohort studyScandinavian Journal of Rheumatology 2021; 50(1): 40 doi: 10.1080/03009742.2020.1732460
6
Kenichi Kishimoto, Kousaku Kawashima, Mai Fukunaga, Satoshi Kotani, Hiroki Sonoyama, Akihiko Oka, Yoshiyuki Mishima, Naoki Oshima, Norihisa Ishimura, Noriyoshi Ishikawa, Riruke Maruyama, Shunji Ishihara. Intermittent Purpura Development Associated with Leukocytoclastic Vasculitis Induced by Infliximab for Crohn's DiseaseInternal Medicine 2021; 60(3): 385 doi: 10.2169/internalmedicine.5340-20
7
Hemal N. Sampat, Brian P. McAllister, Darryl D. Gaines, Barbara Ostrov. Terminal Ileitis as a Feature of Henoch-Schönlein Purpura Masquerading as Crohn Disease in AdultsJCR: Journal of Clinical Rheumatology 2016; 22(2): 82 doi: 10.1097/RHU.0000000000000361
8
Roberto Perez-Alvarez, Marta Pérez-de-Lis, Manuel Ramos-Casals. Biologics-induced autoimmune diseasesCurrent Opinion in Rheumatology 2013; 25(1): 56 doi: 10.1097/BOR.0b013e32835b1366
9
Lindsey G. Albenberg, Petar Mamula, Kurt Brown, Robert N. Baldassano, Pierre Russo. Pathology of Pediatric Gastrointestinal and Liver Disease2014; : 197 doi: 10.1007/978-3-642-54053-0_6
10
Sarah Alsulami, Rakan M Alotaibi, Faisal F Alotaibi, Faisal B Almatrafi, Doaa M Filmban, Sultan Alneefia, AhmedHusam Alahmed, Waleed A Hafiz. IgA Vasculitis With Adalimumab Therapy for Hidradenitis Suppurativa: A Case Report and Review of LiteratureCureus 2022;  doi: 10.7759/cureus.30122
11
Camila da Silva Cendon Duran, Adriane Souza da Paz, Mittermayer Barreto Santiago. Vasculitis induced by biological agents used in rheumatology practice: A systematic reviewArchives of Rheumatology 2022; 37(2): 300 doi: 10.46497/ArchRheumatol.2022.9049
12
Yang Song, Yan-Hong Shi, Chong He, Chang-Qin Liu, Jun-Shan Wang, Yu-Jie Zhao, Yan-Min Guo, Rui-Jin Wu, Xiao-Yue Feng, Zhan-Ju Liu. Severe Henoch-Schönlein purpura with infliximab for ulcerative colitisWorld Journal of Gastroenterology 2015; 21(19): 6082-6087 doi: 10.3748/wjg.v21.i19.6082
13
Carmen Martín Varas, Manuel Heras, Ana Saiz, Raquel Coloma, Leonardo Calle, Ramiro Callejas, Álvaro Molina, María Astrid Rodríguez, María José Fernández-Reyes Luis. Vasculitis asociada a anticuerpo anticitoplasma de neutrófilo en paciente con enfermedad de Crohn en tratamiento con adalimumabNefrología 2017; 37(5): 560 doi: 10.1016/j.nefro.2017.03.009
14
Woo-Jin Jung, Yoon-Jeong Nam, Seung-Geun Lee, Ji-Min Kim, Margaret Song, Moon-Bum Kim, Geun-Tae Kim. Henoch-Schönlein Purpura in a Patient with Ankylosing Spondylitis after Infliximab TherapyKorean Journal of Medicine 2013; 84(5): 764 doi: 10.3904/kjm.2013.84.5.764
15
Morgane Condamina, Emmanuelle Diaz, Céline Jamart, Jeffrey Loget, Anne Durlach, Jean-Hugues Salmon, Guillaume Cadiot, Manuelle Viguier. Severe Attack of Henoch-Schönlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn’s DiseaseJournal of Crohn's and Colitis 2020; 14(4): 538 doi: 10.1093/ecco-jcc/jjz164
16
Iman Hemmati, Jason Kur. Adalimumab-associated antiphospholipid syndrome: a case report and review of the literatureClinical Rheumatology 2013; 32(7): 1095 doi: 10.1007/s10067-013-2244-0
17
Yun Xue, Jeffrey M. Cohen, Natalie A. Wright, Joseph F. Merola. Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side EffectsAmerican Journal of Clinical Dermatology 2016; 17(2): 147 doi: 10.1007/s40257-015-0167-z
18
Dean Edwards, Eli Boritz, Edward W. Cowen, Ronald S. Brown. Erythema multiforme major following treatment with infliximabOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2013; 115(2): e36 doi: 10.1016/j.oooo.2012.08.001
19
Anishka S. Rolle, Bernard Zimmermann, Sam H. Poon. Etanercept-Induced Henoch-Schönlein Purpura in a Patient With Ankylosing SpondylitisJournal of Clinical Rheumatology 2013; 19(2): 90 doi: 10.1097/RHU.0b013e3182863027
20
Shintaro Yamamoto, Tomoyuki Mukai, Shunichi Fujita, Yoshitaka Morita. Certolizumab pegol-induced immunoglobulin A vasculitis in a patient with rheumatoid arthritisMedicine: Case Reports and Study Protocols 2021; 2(1): e0029 doi: 10.1097/MD9.0000000000000029
21
Camille Rasmussen, Vered Abitbol, Khalil El Karoui, Anne Bourrier, Romain Paule, Lucine Vuitton, François Maurier, David Laharie, Mathurin Fuméry, Christian Agard, Michael Collins, Stephane Nancey, Cédric Rafat, Anne-Gaëlle Kervegant, Viviane Queyrel-Moranne, Guillaume Moulis, Bénédicte Pigneur, Alexis Régent, Claire Gay, Caroline Morbieu, Cécile Audrey Durel, Didier Ducloux, François Aubin, Mickaela Voicu, Nizar Joher, Tali Szwebel, Christine Martinez-Vinson, Stéphane Koch, Loïc Guillevin, Laurent Peyrin-Biroulet, Benjamin Terrier. IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-α blockersRheumatology 2022; 61(5): 1957 doi: 10.1093/rheumatology/keab662
22
Inês Marques, Ana Lagos, Jorge Reis, António Pinto, Beatriz Neves. Reversible Henoch–Schönlein purpura complicating adalimumab therapyJournal of Crohn's and Colitis 2012; 6(7): 796 doi: 10.1016/j.crohns.2012.02.019
23
V. Roumieu, A. Darmon, P. Belenotti, A. Benyamine, J. Serratrice, P. Lafforgue, P.J. Weiller. Purpura rhumatoïde sous anti-TNF : à propos de deux casLa Revue de Médecine Interne 2014; 35: A117 doi: 10.1016/j.revmed.2014.10.195
24
M. Reverte, M. Etienne, M. Fouchard, L. Doucet, E. Brenaut, L. Misery. Occurrence of Henoch–Schönlein purpura in a patient treated with secukinumabJournal of the European Academy of Dermatology and Venereology 2019; 33(12) doi: 10.1111/jdv.15776
25
Carmen Martín Varas, Manuel Heras, Ana Saiz, Raquel Coloma, Leonardo Calle, Ramiro Callejas, Álvaro Molina, María Astrid Rodríguez, María José Fernández-Reyes Luis. Antineutrophil cytoplasmic antibodies associated vasculitis in patient with Crohn's disease treated with adalimumabNefrología (English Edition) 2017; 37(5): 560 doi: 10.1016/j.nefroe.2017.09.006